2001
Epibatidine and analogs - New trends in the development of cognitive enhancers and strong analgetics
PATOČKA, Jiří; Kräuff SCHWANHAEUSER WULFF a María Victoria MARINI PALOMEQUEZákladní údaje
Originální název
Epibatidine and analogs - New trends in the development of cognitive enhancers and strong analgetics
Název česky
Epibatidine a jeji analogy - Novy trendy
Autoři
PATOČKA, Jiří; Kräuff SCHWANHAEUSER WULFF a María Victoria MARINI PALOMEQUE
Vydání
Vojenské zdravotnické listy, Hradec Králové, Czech Republic, Vojenská lékařská akademie J.E. Purkyně, 2001, 0372-7025
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30104 Pharmacology and pharmacy
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Označené pro přenos do RIV
Ano
Organizační jednotka
Lékařská fakulta
Klíčová slova anglicky
epibatidine;analgetics;poison-dart frog; alkaloid; nicotinic acetylcholine agonist;dementia;Alzheimer's disease;pain;toxin
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 25. 1. 2008 17:29, MUDr. Kräuff Rainer Schwanhaeuser Wulff, MBA, Ph.D. et Ph.D., M.A.
V originále
Epibatidine, the natural alkaloid isolated from the skin of the Ecuatorian rainforest poison-dart frog. Epipedobates tricolor and some of its synthetically prepared analogs are strong selective agonists of the nicotinic acetylcholine receptors. All of these substances have an analgesic effect and could be used in medical practice. This is very promising for medicine in the fight against pain as well as against dementia, because nicotinic agonists have been found to improve the performance of a variety of memory tasks in rodents and they are probably beneficial in Alzheimer's disease treatment.
Česky
Epibatidine, the natural alkaloid isolated from the skin of the Ecuatorian rainforest poison-dart frog. Epipedobates tricolor and some of its synthetically prepared analogs are strong selective agonists of the nicotinic acetylcholine receptors. All of these substances have an analgesic effect and could be used in medical practice. This is very promising for medicine in the fight against pain as well as against dementia, because nicotinic agonists have been found to improve the performance of a variety of memory tasks in rodents and they are probably beneficial in Alzheimer's disease treatment.